Cargando…

Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis

We analysed cancer risks in patients with urinary tract stones but some features of the generated results alarmed us about possible surveillance bias, which we describe in this report. We used nationwide Swedish hospital records to identify patients with urinary tract stones (N = 211,718) and cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemminki, Kari, Hemminki, Otto, Försti, Asta, Sundquist, Kristina, Sundquist, Jan, Li, Xinjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556042/
https://www.ncbi.nlm.nih.gov/pubmed/28808281
http://dx.doi.org/10.1038/s41598-017-08839-5
_version_ 1783256991560368128
author Hemminki, Kari
Hemminki, Otto
Försti, Asta
Sundquist, Kristina
Sundquist, Jan
Li, Xinjun
author_facet Hemminki, Kari
Hemminki, Otto
Försti, Asta
Sundquist, Kristina
Sundquist, Jan
Li, Xinjun
author_sort Hemminki, Kari
collection PubMed
description We analysed cancer risks in patients with urinary tract stones but some features of the generated results alarmed us about possible surveillance bias, which we describe in this report. We used nationwide Swedish hospital records to identify patients with urinary tract stones (N = 211,718) and cancer registration data for cancer patients for years 1987 to 2012. Standardized incidence ratios (SIRs) for cancer were calculated after the last medical contact for urinary tract stones. All cancers were increased after kidney (SIR 1.54, 95%CI: 1.50–1.58), ureter (1.44, 1.42–1.47), mixed (1.51, 1.44–1.58) and bladder stones (1.63, 1.57–1.70). The risk of kidney cancer was increased most of all cancers after kidney, ureter and mixed stones while bladder cancer was increased most after bladder stones. All SIRs decreased steeply in the course of follow-up time. Tumour sizes were smaller in kidney cancer and in situ colon cancers were more common in patients diagnosed after urinary tract stones compared to all patients. The results suggest that surveillance bias influenced the result which somewhat surprisingly appeared to extend past 10 years of follow-up and include cancers at distant anatomical sites. Surveillance bias may be difficult to avoid in the present type of observational studies in clinical settings.
format Online
Article
Text
id pubmed-5556042
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55560422017-08-16 Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis Hemminki, Kari Hemminki, Otto Försti, Asta Sundquist, Kristina Sundquist, Jan Li, Xinjun Sci Rep Article We analysed cancer risks in patients with urinary tract stones but some features of the generated results alarmed us about possible surveillance bias, which we describe in this report. We used nationwide Swedish hospital records to identify patients with urinary tract stones (N = 211,718) and cancer registration data for cancer patients for years 1987 to 2012. Standardized incidence ratios (SIRs) for cancer were calculated after the last medical contact for urinary tract stones. All cancers were increased after kidney (SIR 1.54, 95%CI: 1.50–1.58), ureter (1.44, 1.42–1.47), mixed (1.51, 1.44–1.58) and bladder stones (1.63, 1.57–1.70). The risk of kidney cancer was increased most of all cancers after kidney, ureter and mixed stones while bladder cancer was increased most after bladder stones. All SIRs decreased steeply in the course of follow-up time. Tumour sizes were smaller in kidney cancer and in situ colon cancers were more common in patients diagnosed after urinary tract stones compared to all patients. The results suggest that surveillance bias influenced the result which somewhat surprisingly appeared to extend past 10 years of follow-up and include cancers at distant anatomical sites. Surveillance bias may be difficult to avoid in the present type of observational studies in clinical settings. Nature Publishing Group UK 2017-08-14 /pmc/articles/PMC5556042/ /pubmed/28808281 http://dx.doi.org/10.1038/s41598-017-08839-5 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Hemminki, Kari
Hemminki, Otto
Försti, Asta
Sundquist, Kristina
Sundquist, Jan
Li, Xinjun
Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis
title Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis
title_full Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis
title_fullStr Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis
title_full_unstemmed Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis
title_short Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis
title_sort surveillance bias in cancer risk after unrelated medical conditions: example urolithiasis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556042/
https://www.ncbi.nlm.nih.gov/pubmed/28808281
http://dx.doi.org/10.1038/s41598-017-08839-5
work_keys_str_mv AT hemminkikari surveillancebiasincancerriskafterunrelatedmedicalconditionsexampleurolithiasis
AT hemminkiotto surveillancebiasincancerriskafterunrelatedmedicalconditionsexampleurolithiasis
AT forstiasta surveillancebiasincancerriskafterunrelatedmedicalconditionsexampleurolithiasis
AT sundquistkristina surveillancebiasincancerriskafterunrelatedmedicalconditionsexampleurolithiasis
AT sundquistjan surveillancebiasincancerriskafterunrelatedmedicalconditionsexampleurolithiasis
AT lixinjun surveillancebiasincancerriskafterunrelatedmedicalconditionsexampleurolithiasis